CLASS II Drug recall · Reported 31 Jul 2019 · FDA Enforcement Report

Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg recalled

Lupin Pharmaceuticals is recalling Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, distributed nationwide in the US. The recall was initiated on 19 Jul 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #:H801815, Exp. March 2021
NDC68180-518, 68180-519, 68180-520
UPC0368180519010, 0368180518013, 0368180520016
Quantity recalled11,832 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1581-2019
FDA event ID
83363
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class II
Status
Terminated
Recall initiated
19 Jul 2019
FDA classified
31 Jul 2019
Reported
31 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

19 Jul 2019Recall initiated by company
31 Jul 2019Classified by FDA+12 days
31 Jul 2019Published in enforcement report+0 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Product as listed by the FDA

Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Which lots are affected?

Lot #:H801815, Exp. March 2021

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 0.05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide

Other Lisinopril recalls

All 38